122 related articles for article (PubMed ID: 8071320)
21. Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human alpha-thrombin.
Féthière J; Tsuda Y; Coulombe R; Konishi Y; Cygler M
Protein Sci; 1996 Jun; 5(6):1174-83. PubMed ID: 8762149
[TBL] [Abstract][Full Text] [Related]
22. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ
Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168
[TBL] [Abstract][Full Text] [Related]
23. Evidence for common structural changes in thrombin induced by active-site or exosite binding.
Parry MA; Stone SR; Hofsteenge J; Jackman MP
Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):665-70. PubMed ID: 8457193
[TBL] [Abstract][Full Text] [Related]
24. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
[TBL] [Abstract][Full Text] [Related]
25. Hirunorms are true hirudin mimetics. The crystal structure of human alpha-thrombin-hirunorm V complex.
De Simone G; Lombardi A; Galdiero S; Nastri F; Della Morte R; Staiano N; Pedone C; Bolognesi M; Pavone V
Protein Sci; 1998 Feb; 7(2):243-53. PubMed ID: 9521099
[TBL] [Abstract][Full Text] [Related]
26. The structure of a designed peptidomimetic inhibitor complex of alpha-thrombin.
Wu TP; Yee V; Tulinsky A; Chrusciel RA; Nakanishi H; Shen R; Priebe C; Kahn M
Protein Eng; 1993 Jul; 6(5):471-8. PubMed ID: 8415574
[TBL] [Abstract][Full Text] [Related]
27. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.
Bode W; Turk D; Karshikov A
Protein Sci; 1992 Apr; 1(4):426-71. PubMed ID: 1304349
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, structure, and structure-activity relationships of divalent thrombin inhibitors containing an alpha-keto-amide transition-state mimetic.
Krishnan R; Tulinsky A; Vlasuk GP; Pearson D; Vallar P; Bergum P; Brunck TK; Ripka WC
Protein Sci; 1996 Mar; 5(3):422-33. PubMed ID: 8868478
[TBL] [Abstract][Full Text] [Related]
29. Thrombin-bound conformation of the C-terminal fragments of hirudin determined by transferred nuclear Overhauser effects.
Ni F; Konishi Y; Scheraga HA
Biochemistry; 1990 May; 29(18):4479-89. PubMed ID: 2350549
[TBL] [Abstract][Full Text] [Related]
30. Thermodynamic investigation of hirudin binding to the slow and fast forms of thrombin: evidence for folding transitions in the inhibitor and protease coupled to binding.
Ayala YM; Vindigni A; Nayal M; Spolar RS; Record MT; Di Cera E
J Mol Biol; 1995 Nov; 253(5):787-98. PubMed ID: 7473752
[TBL] [Abstract][Full Text] [Related]
31. Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen A alpha: geometry of the catalytic triad and interactions of the P1', P2', and P3' substrate residues.
Martin PD; Malkowski MG; DiMaio J; Konishi Y; Ni F; Edwards BF
Biochemistry; 1996 Oct; 35(40):13030-9. PubMed ID: 8855938
[TBL] [Abstract][Full Text] [Related]
32. Crystal structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6.
Zdanov A; Wu S; DiMaio J; Konishi Y; Li Y; Wu X; Edwards BF; Martin PD; Cygler M
Proteins; 1993 Nov; 17(3):252-65. PubMed ID: 8272424
[TBL] [Abstract][Full Text] [Related]
33. The effects of exosite occupancy on the substrate specificity of thrombin.
Ng NM; Quinsey NS; Matthews AY; Kaiserman D; Wijeyewickrema LC; Bird PI; Thompson PE; Pike RN
Arch Biochem Biophys; 2009 Sep; 489(1-2):48-54. PubMed ID: 19638274
[TBL] [Abstract][Full Text] [Related]
34. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
[TBL] [Abstract][Full Text] [Related]
35. Probing the hirudin-thrombin interaction by incorporation of noncoded amino acids and molecular dynamics simulation.
De Filippis V; Colombo G; Russo I; Spadari B; Fontana A
Biochemistry; 2002 Nov; 41(46):13556-69. PubMed ID: 12427016
[TBL] [Abstract][Full Text] [Related]
36. The crystal structure of human alpha-thrombin complexed with LY178550, a nonpeptidyl, active site-directed inhibitor.
Chirgadze NY; Sall DJ; Klimkowski VJ; Clawson DK; Briggs SL; Hermann R; Smith GF; Gifford-Moore DS; Wery JP
Protein Sci; 1997 Jul; 6(7):1412-7. PubMed ID: 9232642
[TBL] [Abstract][Full Text] [Related]
37. Intrinsic fluorescence changes and rapid kinetics of the reaction of thrombin with hirudin.
Jackman MP; Parry MA; Hofsteenge J; Stone SR
J Biol Chem; 1992 Aug; 267(22):15375-83. PubMed ID: 1639783
[TBL] [Abstract][Full Text] [Related]
38. The dual role of thrombin's anion-binding exosite-I in the recognition and cleavage of the protease-activated receptor 1.
Myles T; Le Bonniec BF; Stone SR
Eur J Biochem; 2001 Jan; 268(1):70-7. PubMed ID: 11121104
[TBL] [Abstract][Full Text] [Related]
39. Structure of a nonadecapeptide of the fifth EGF domain of thrombomodulin complexed with thrombin.
Mathews II; Padmanabhan KP; Tulinksy A; Sadler JE
Biochemistry; 1994 Nov; 33(46):13547-52. PubMed ID: 7947765
[TBL] [Abstract][Full Text] [Related]
40. Nonpolar interactions of thrombin and its inhibitors at the fibrinogen recognition exosite: thermodynamic analysis.
Cheng Y; Slon-Usakiewicz JJ; Wang J; Purisima EO; Konishi Y
Biochemistry; 1996 Oct; 35(40):13021-9. PubMed ID: 8855937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
